Navigation Links
Conflicts of Interest Still Exist in Cancer Research
Date:5/11/2009

Medical journals need to be more vigilant, analysis suggests

MONDAY, May 11 (HealthDay News) -- A recent analysis of major medical journals has found many potential conflicts of interest between researchers and medical industry companies, raising concern that investigators may at least be tempted to report favorable results to help the financial backers of their work.

The analysis, to be published in the June 15 issue of Cancer and headed by the University of Michigan, looked at more than 1,500 cancer studies published in eight authoritative journals, including Cancer, the New England Journal of Medicine and the Lancet, during a recent year and found:

  • Randomized clinical trials that assessed patient survival were more likely to link a survival advantage to the medical treatment being studied when a conflict of interest was present.
  • These trials, the authors noted, are how drugs, technologies, procedures and so on eventually get approved for use in medical practices.
  • Apparent conflicts of interest (such as industry funding, consulting fees to authors and co-authorship by industry employees) found simply by reviewing the authorship credits were noted in 29 percent of studies, while 17 percent actually declared industry funding.
  • Industry-funded studies focused on treatment in 62 percent of cases, whereas only 36 percent of studies done without industry funding focused on treatment.
  • While 47 percent of studies done without industry funding looked at epidemiology, prevention, risk factors, screening or diagnostic methods, only 20 percent of industry-funded studies focused on these areas.

Researchers are often required to disclose potential conflicts of interest to medical journals when they submit articles, but the lines can get blurry. While taking a consulting fee or holding a job in the companies whose products they are evaluating is an obvious potential conflict of interest, some researchers may knowingly or unknowingly hold stock in the companies, for example.

As a result, the authors of the analysis wrote that "attempts to disentangle the cancer research effort from industry merit further attention, and journals should embrace both rigorous standards of disclosure and heightened scrutiny when conflicts exist."

More information

The U.S. National Cancer Institute has more about cancer.



-- Kevin McKeever



SOURCE: American Cancer Society, news release, May 11, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Review finds conflicts of interest in many cancer studies
2. Argus Honored by Flaspohler Research Group as Highest-Rated PBM for No Conflicts of Interest
3. Conflicts of interest in clinical research
4. New Book Exposes Junk Science, Conflicts of Interest, Disease Guidelines Affecting Millions
5. The health care industry -- a system fraught with conflicts
6. Kevin P. Miller's Film "Generation RX" Reveals Widespread Ethical Conflicts, Risks of Psychiatric Drugs to Children
7. Work Conflicts Can Do a Job on Your Sleep
8. Clinical trial volunteers mostly indifferent -- but not blind to -- researchers financial conflicts
9. Mother-child attachment, childrens temperament play a role in terrible 2 conflicts
10. New book sheds light on conflicts of politics and science
11. Stem Cell Institute Correct in Rejecting Applications Over Conflicts of Interest; Institutions, Board Members Involved Must Be Identified, Consumer Advocates Say
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Conflicts of Interest Still Exist in Cancer Research
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history ... The Brink” is the creation of published author, William Nowers. Captain Nowers and ... WWII veteran, he spent thirty years in the Navy. Following his career as ...
(Date:10/12/2017)... ... October 12, 2017 , ... The ... demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, ... to meet the highest standard. , These products are also: Gluten Free, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
(Date:10/12/2017)... , ... October 12, 2017 , ... On Saturday, October ... treadmill relay – Miles by Moonlight to raise money for the American Heart Association ... more. , Teams will work together to keep their treadmills moving for 5 ...
(Date:10/12/2017)... ... October 12, 2017 , ... Vohra Chief ... advancements to physician colleagues, skilled nursing facility medical directors and other clinicians at ... of Wound Care." , "At many of these conferences we get to educate ...
Breaking Medicine News(10 mins):
(Date:9/22/2017)... 22, 2017 AVACEN Medical (AVACEN) announced that ... successfully helping those with the widespread pain associated with ... Amanda in Essex, England commented, ... hair, experiencing no sleep at all, tremendous pain, with ... cannot recommend [the AVACEN 100] enough, how this has ...
(Date:9/18/2017)... 18, 2017 EpiVax, Inc. ("EpiVax") ... and immune engineering, today announced a new ... (H7N9) vaccine. ... influenza and presents a challenge for traditional ... to be effective. Using state-of-the-art bioinformatics and molecular ...
(Date:9/12/2017)... 2017  ValGenesis Inc., the global leader in ... to announce the appointment of Dr. Ajaz ... of Directors and Chairman of Advisory Board beginning ... companies to manage their entire validation lifecycle process ... this process. Furthermore, ValGenesis VLMS enables rigorous compliance, ...
Breaking Medicine Technology: